FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts

American Journal of Pathology

Volumn 171, Issue 5, 2007, Pages 1499-1508

  Miyagawa Hayashino, Aya ^a   Tsuruyama, Tatsuaki ^a,b   Egawa, Hiroto ^a   Haga, Hironori ^a   Sakashita, Hiromi ^a   Okuno, Tomoko ^a,b   Toyokuni, Shinya ^b   Tamaki, Keiji ^b   Yamabe, Hirohiko ^a   Manabe, Toshiaki ^a   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; INTERLEUKIN 4;

ADOLESCENT; ADULT; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CHOLANGITIS; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; KUPFFER CELL; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NEWBORN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 36349035436     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070027     Document Type: Article

References (45)

1. Clouston AD, Jonsson JR, Balderson GA, Fawcett J, Lynch SV, Kelso A, Powell EE: Lymphocyte apoptosis and cell replacement in human liver allografts. Transplantation 2002, 73:1828-1834
2. Knolle PA, Gerken G: Local control of the immune response in the liver. Immunol Rev 2000, 174:21-34
3. Crispe I: Hepatic T cells and liver tolerance. Nat Rev Immunol 2003, 3:51-62
4. Qian S, Lu L, Fu F, Li Y, Li W, Starzl TE, Fung JJ, Thomson AW: Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997, 158:4654-4661
5. Sharland A, Yan Y, Wang C, Bowen DG, Sun J, Sheil AG, McCaughan GW, Bishop GA: Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation 1999, 68:1736-1745
6. Sun Z, Wada T, Maemura K, Uchikura K, Hoshino S, Diehl AM, Klein AS: Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Liver Transpl 2003, 9:489-497
7. Josien R, Muschen M, Gilbert E, Douillard P, Heslan JM, Soulillou JP, Cuturi MC: Fas ligand, tumor necrosis factor-α expression, and apoptosis during allograft rejection and tolerance. Transplantation 1998, 66:887-893
8. Afford SC, Randhawa S, Eliopoulos AG, Hubscher SG, Young LS, Adams DH: CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection. J Exp Med 1999, 189:441-446
9. Tannapfel A, Kohlhaw K, Ebelt J, Hauss J, Liebert U, Berr F, Wittekind C: Apoptosis and the expression of Fas and Fas ligand (FasL) antigen in rejection and reinfection in liver allograft specimens. Transplantation 1999, 67:1079-1083
10. Rivero M, Crespo J, Mayorga M, Fabrega E, Casafont F, Pons-Romero F: Involvement of the Fas system in liver allograft rejection. Am J Gastroenterol 2002, 97:1501-1506
11. Nagata S: Fas ligand and immune evasion. Nat Med 1996, 2:1306-1307
12. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365
13. Dresske B, Lin X, Huang DS, Zhou X, Fandrich F: Spontaneous tolerance: experience with the rat liver transplant model. Hum Immunol 2002, 63:853-861
14. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997, 25:658-663
15. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, Fung J, Gouw A, Gustafsson B, Haga H, Harrison D, Hart J, Hubscher S, Jaffe R, Khettry U, Lassman C, Lewin K, Martinez O, Nakazawa Y, Neil D, Pappo O, Parizhskaya M, Randhawa P, Rasoul-Rockenschaub S, Reinholt F, Reynes M, Robert M, Tsamandas A, Wanless I, Wiesner R, Wernerson A, Wrba F, Wyatt J, Yamabe H: Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000, 31:792-799
16. Neil DA, Hubscher SG: Histologic and biochemical changes during the evolution of chronic rejection of liver allografts. Hepatology 2002, 35:639-651
17. Sebagh M, Yilmaz F, Karam V, Falissard B, Roche B, Azoulay D, Samuel D, Guettier C: The histologic pattern of "biliary tract pathology" is accurate for the diagnosis of biliary complications. Am J Surg Pathol 2005, 29:318-323
18. Coffmann RL, Seymour BW, Lebman DA, Hiraki DD, Christiansen JA, Shrader B, Cherwinski HM, Savelkoul HF, Bond MW, Finkelman FD: The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988, 102:5-28
19. Miyagawa-Hayashino A, Tsuruyama T, Haga H, Oike F, II-Deok K, Egawa H, Hiai H, Tanaka K, Manabe T: Arteriopathy in chronic allograft rejection in liver transplantation. Liver Transpl 2004, 10:513-519
20. Benhattar J, Delacretaz F, Martin P, Chaubert P, Costa J: Improved polymerase chain reaction detection of clonal T-cell lymphoid neoplasms. Diagn Mol Pathol 1995, 4:108-112
21. Haga H, Kobashi Y, Yuba Y, Kanehira K, Sakamoto S, Yamabe H: Use of polymerase chain reaction of the T-cell receptor gamma gene from paraffin-embedded tissue in diagnosis of T-cell lymphomas. Tenri Med Bull 1998, 1:19-27
22. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 1995, 377:630-632
23. Pan TL, Goto S, Lin YC, Lord R, Chiang KC, Lai CY, Chen YS, Eng HL, Cheng YF, Tatsuma T, Kitano S, Un CL, Chen CL: The fas and fas ligand pathways in liver allograft tolerance. Clin Exp Immunol 1999, 118:180-187
24. Yang J, Gallagher SF, Haines K, Epling-Burnette PK, Bai F, Gower WR Jr, Mastorides S, Norman JG, Murr MM: Kupffer cell-derived Fas ligand plays a role in liver injury and hepatocyte death, J Gastrointest Surg 2004, 8:166-174
25. Mita A, Hashikura Y, Tagawa Y, Nakayama J, Kawakubo M, Miyagawa S: Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure. Am J Gastroenterol 2005, 100:2551-2559
26. Duncan SR, Valentine V, Roglic M, Elias DJ, Pekny KW, Theodore J, Kono DH, Theofilopoulos AN: T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis. J Clin Invest 1996, 97:2642-2650
27. + T cell expansions in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med 2002, 165:1439-1444
28. Hagihara M, Hiraga S, Tsuchida F, Morita N, Kanai N, Balgansuren G, Munkhbat B, Masuko K, Yamamoto K, Kato S, Tsuji K: T-cell clonal change after allo-kidney transplantation in humans. Scand J Immunol 1998, 48:300-306
29. Kusaka S, Grailer AP, Fechner JH, Jankowska-Gan E, Oberley T, Sollinger HW, Burlingham WJ: Clonotype analysis of human alloreactive T cells: a novel approach to studying peripheral tolerance in a transplant recipient. J Immunol 2000, 164:2240-2247
30. Baron C, McMorrow I, Sachs DH, LeGuern C: Persistence of dominant T cell clones in accepted solid organ transplants. J Immunol 2001, 167:4154-4160
31. Shirwan H, Chi D, Makowka L, Cramer DV: Lymphocytes infiltrating rat cardiac allografts express a limited repertoire of T cell receptor V beta genes. J Immunol 1993, 151:5228-5238
32. Xu B, Sakkas LI, Goldman BI, Jeevanandam V, Gaughan J, Oleszak EL, Platsoucas CD: Identical α-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection. Cell Immunol 2003, 225:75-90
33. Molajoni ER, Cinti P, Orlandini A, Molajoni J, Tugulea S, Ho E, Liu Z, Suciu-Foca N, Cortesini R: Mechanism of liver allograft rejection: the indirect recognition pathway. Hum Immunol 1997, 53:57-63
34. Ciubotariu R, Liu Z, Colovai AI, Ho E, Itescu S, Ravalli S, Hardy MA, Cortesini R, Rose EA, Suciu-Foca N: Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998, 101:398-405
35. Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, Sato T, Reed JC, Green D, Swain SL: Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 1997, 185:1837-1849
36. + T cells produce different cytokines during rejection and tolerance in response to stimulation. J Gastrointest Surg 2002, 6:455-463
37. Shirwan H: Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation 1999, 68:715-726
38. Sumitran-Holgersson S, Ge X, Karrar A, Xu B, Nava S, Broome U, Nowak G, Ericzon BG: A novel mechanism of liver allograft rejection facilitated by antibodies to liver sinusoidal endothelial cells. Hepatology 2004, 40:1211-1221
39. Katz SC, Pillarisetty VG, Bleier JI, Shah AB, DeMatteo RP: Liver sinusoidal endothelial cells are insufficient to activate T cells. J Immunol 2004, 173:230-235 40. Shnyra A, Lindberg AA: Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro. Infect Immun 1995, 63:865-873
40. Vierling J: Immunologic mechanisms of hepatic allograft rejection. Semin Liver Dis 1992, 12:16-27
41. Walsh PT, Strom TB, Turka LA: Routes to transplant tolerance versus rejection; the role of cytokines. Immunity 2004, 20:121-131
42. Via CS, Nguyen P, Shustov A, Drappa J, Elkon KB: A major role for the Fas pathway in acute graft-versus-host disease. J Immunol 1996, 157:5387-5393
43. + T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med 2002, 8:233-239
44. Pons JA, Yelamos J, Ramirez P, Oliver-Bonet M, Sanchez A, Rodriguez-Gago M, Navarro J, Bermejo J, Robles R, Parrilla P: Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation 2003, 75:1045-1047
45. Tanaka Y, Haga H, Egawa H, Okuno T, Miyagawa-Hayashino A, Tsuruyama T, Kambe M, Marusawa H, Chiba T, Manabe T: Intragraft expression of recipient-type ABO blood group antigens: long-term follow-up and histological features after liver transplantation. Liver Transpl 2005, 11:547-554